The DA VINCI study, a phase II study, tries to determine whether different doses and dosing regimens of intravitreal vascular endothelial growth factor (VEGF) Trap-Eye are superior to focal/grid photocoagulation in eyes with diabetic macular edema (DME). Here, VEGFA is linked to diabetic macular edema.